JP2011502968A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011502968A5 JP2011502968A5 JP2010531519A JP2010531519A JP2011502968A5 JP 2011502968 A5 JP2011502968 A5 JP 2011502968A5 JP 2010531519 A JP2010531519 A JP 2010531519A JP 2010531519 A JP2010531519 A JP 2010531519A JP 2011502968 A5 JP2011502968 A5 JP 2011502968A5
- Authority
- JP
- Japan
- Prior art keywords
- preparation according
- preparation
- luteinizing hormone
- concentration
- hlh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07119832 | 2007-11-01 | ||
| EP07119832.9 | 2007-11-01 | ||
| US448107P | 2007-11-28 | 2007-11-28 | |
| US61/004,481 | 2007-11-28 | ||
| PCT/EP2008/064679 WO2009056569A1 (en) | 2007-11-01 | 2008-10-29 | Lh liquid formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011502968A JP2011502968A (ja) | 2011-01-27 |
| JP2011502968A5 true JP2011502968A5 (enExample) | 2011-12-22 |
| JP5551601B2 JP5551601B2 (ja) | 2014-07-16 |
Family
ID=39167502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010531519A Active JP5551601B2 (ja) | 2007-11-01 | 2008-10-29 | Ｌｈ液体調製物 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8664369B2 (enExample) |
| EP (1) | EP2219607B1 (enExample) |
| JP (1) | JP5551601B2 (enExample) |
| KR (1) | KR101513181B1 (enExample) |
| CN (1) | CN101842083B (enExample) |
| AU (1) | AU2008320844B2 (enExample) |
| BR (1) | BRPI0818324B8 (enExample) |
| CA (1) | CA2700662C (enExample) |
| CY (1) | CY1113121T1 (enExample) |
| DK (1) | DK2219607T3 (enExample) |
| EA (1) | EA019432B1 (enExample) |
| EC (1) | ECSP10010224A (enExample) |
| ES (1) | ES2393233T3 (enExample) |
| HR (1) | HRP20120660T1 (enExample) |
| IL (1) | IL205105A (enExample) |
| MX (1) | MX2010004639A (enExample) |
| MY (1) | MY153976A (enExample) |
| NZ (1) | NZ583991A (enExample) |
| PL (1) | PL2219607T3 (enExample) |
| PT (1) | PT2219607E (enExample) |
| RS (1) | RS52566B (enExample) |
| SI (1) | SI2219607T1 (enExample) |
| UA (1) | UA101484C2 (enExample) |
| WO (1) | WO2009056569A1 (enExample) |
| ZA (1) | ZA201001907B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY152979A (en) | 2008-01-09 | 2014-12-15 | Sanofi Aventis Deutschland | Novel insulin derivatives having an extremely delayed time-action profile |
| RS59913B1 (sr) | 2008-10-17 | 2020-03-31 | Sanofi Aventis Deutschland | Kombinacija insulina i glp-1-agonista |
| JP2011001273A (ja) * | 2009-06-16 | 2011-01-06 | Eci Inc | ｅＭＩＰを有効成分とする水溶性製剤 |
| CN102596175A (zh) | 2009-07-06 | 2012-07-18 | 赛诺菲-安万特德国有限公司 | 含有甲硫氨酸的水性胰岛素制备物 |
| MY180661A (en) | 2009-11-13 | 2020-12-04 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine |
| PT3345593T (pt) | 2009-11-13 | 2023-11-27 | Sanofi Aventis Deutschland | Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina |
| RU2553375C2 (ru) * | 2010-02-12 | 2015-06-10 | Интас Биофармасьютикалс Лимитед | Жидкий состав фолликулостимулирующего гормона |
| PL2611458T3 (pl) | 2010-08-30 | 2017-02-28 | Sanofi-Aventis Deutschland Gmbh | Zastosowanie AVE0010 do produkcji leku do leczenia cukrzycy typu 2 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| CN102293756A (zh) * | 2011-08-24 | 2011-12-28 | 蚌埠丰原涂山制药有限公司 | 一种尿促性素冻干粉针剂及其制备方法 |
| AR087693A1 (es) | 2011-08-29 | 2014-04-09 | Sanofi Aventis Deutschland | Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2 |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| MX2015006997A (es) * | 2012-12-26 | 2015-09-23 | Wockhardt Ltd | Composicion farmaceutica. |
| TWI780236B (zh) | 2013-02-04 | 2022-10-11 | 法商賽諾菲公司 | 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物 |
| EP2968391A1 (en) | 2013-03-13 | 2016-01-20 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| MX2016008978A (es) | 2014-01-09 | 2016-10-04 | Sanofi Sa | Formulaciones farmaceuticas de analogos de insulina y/o derivados de insulina estabilizadas y que estan libres de glicerol. |
| MX2016008979A (es) | 2014-01-09 | 2016-10-04 | Sanofi Sa | Formulaciones farmaceuticas estabilizadas de analogos de insulina y/o derivados de insulina. |
| BR112016015851A2 (pt) | 2014-01-09 | 2017-08-08 | Sanofi Sa | Formulações farmacêuticas estabilizadas de insulina aspart |
| EP3229828B1 (en) | 2014-12-12 | 2023-04-05 | Sanofi-Aventis Deutschland GmbH | Insulin glargine/lixisenatide fixed ratio formulation |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
| GB201603280D0 (en) * | 2016-02-24 | 2016-04-13 | Ferring Bv | Stable liquid gonadotropin formulation |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE64738B1 (en) * | 1990-03-20 | 1995-09-06 | Akzo Nv | Stabilized gonadotropin containing preparations |
| IT1250075B (it) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
| US5681302A (en) * | 1994-06-14 | 1997-10-28 | Minnesota Mining And Manufacturing Company | Elastic sheet-like composite |
| PT814841E (pt) * | 1995-03-21 | 2002-03-28 | Applied Research Systems | Formulacoes liquidas de hcg |
| IL122732A0 (en) * | 1997-01-15 | 1998-08-16 | Akzo Nobel Nv | Liquid gonadotropin-containing formulation its preparation and a device containing same |
| IL140984A0 (en) * | 1998-07-23 | 2002-02-10 | Lilly Co Eli | Fsh and fsh variant formulations, products and methods |
| DE602004019761D1 (de) * | 2003-01-08 | 2009-04-16 | Novartis Vaccines & Diagnostic | Stabilisierte wässrige zusammensetzungen mit gewebefaktorinhibitor (tfpi) oder gewebefaktorinhibitor-variante |
| US7387998B2 (en) | 2003-03-28 | 2008-06-17 | New York University | STQ peptides |
| DK1610822T4 (en) * | 2003-04-02 | 2019-01-14 | Ares Trading Sa | Liquid pharmaceutical FSH and LH formulations together with a nonionic surfactant |
-
2008
- 2008-10-29 BR BRPI0818324A patent/BRPI0818324B8/pt active IP Right Grant
- 2008-10-29 PT PT08844750T patent/PT2219607E/pt unknown
- 2008-10-29 MX MX2010004639A patent/MX2010004639A/es active IP Right Grant
- 2008-10-29 CN CN2008801145250A patent/CN101842083B/zh active Active
- 2008-10-29 SI SI200830735T patent/SI2219607T1/sl unknown
- 2008-10-29 NZ NZ583991A patent/NZ583991A/en unknown
- 2008-10-29 MY MYPI2010001950A patent/MY153976A/en unknown
- 2008-10-29 CA CA2700662A patent/CA2700662C/en not_active Expired - Fee Related
- 2008-10-29 PL PL08844750T patent/PL2219607T3/pl unknown
- 2008-10-29 US US12/681,688 patent/US8664369B2/en active Active
- 2008-10-29 KR KR1020107012131A patent/KR101513181B1/ko active Active
- 2008-10-29 ES ES08844750T patent/ES2393233T3/es active Active
- 2008-10-29 WO PCT/EP2008/064679 patent/WO2009056569A1/en not_active Ceased
- 2008-10-29 AU AU2008320844A patent/AU2008320844B2/en active Active
- 2008-10-29 DK DK08844750.3T patent/DK2219607T3/da active
- 2008-10-29 RS RS20120484A patent/RS52566B/sr unknown
- 2008-10-29 EA EA201070549A patent/EA019432B1/ru not_active IP Right Cessation
- 2008-10-29 UA UAA201006712A patent/UA101484C2/ru unknown
- 2008-10-29 EP EP08844750A patent/EP2219607B1/en active Active
- 2008-10-29 HR HRP20120660AT patent/HRP20120660T1/hr unknown
- 2008-10-29 JP JP2010531519A patent/JP5551601B2/ja active Active
-
2010
- 2010-03-17 ZA ZA2010/01907A patent/ZA201001907B/en unknown
- 2010-04-15 IL IL205105A patent/IL205105A/en active IP Right Grant
- 2010-05-31 EC EC2010010224A patent/ECSP10010224A/es unknown
-
2012
- 2012-09-13 CY CY20121100836T patent/CY1113121T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011502968A5 (enExample) | ||
| HRP20120660T1 (hr) | Tekuće formulacije lh | |
| HRP20200998T1 (hr) | Postupak i sastav za liječenje okularne hipertenzije i glaukoma | |
| FI4374878T3 (fi) | Karbetosiinia käsittävä farmaseuttinen koostumus | |
| JP2013543492A5 (enExample) | ||
| KR101940341B1 (ko) | 약학 조성물 | |
| JP2012519695A5 (enExample) | ||
| US20250195439A1 (en) | Method for treating local lesion disease | |
| AR067011A1 (es) | Formulaciones de anticuerpos | |
| HRP20110444T1 (hr) | Formulacije paratiroidnih hormona i njihove uporabe | |
| CN102821782B (zh) | 促卵泡激素的液体配制品 | |
| TW201542239A (zh) | 穩定液體調配物 | |
| RU2015119603A (ru) | Стабильная фармацевтическая композиция на основе слитого белка tnfr:fc | |
| JP2015535237A5 (enExample) | ||
| JP2018532806A5 (enExample) | ||
| JP2009521473A5 (enExample) | ||
| JP5149308B2 (ja) | 局所的鼻腔投与のためのオロパタジンの製剤 | |
| WO2017073798A1 (ja) | 鼻粘膜投与用医薬組成物 | |
| HRP20211696T1 (hr) | Postupak izrade fluoriranih olefina | |
| CN100553674C (zh) | 一种重组人甲状旁腺激素(1-84)药物组合物及其制备方法 | |
| TWI299993B (en) | Aqueous inhalation pharmaceutical composition | |
| AR067047A1 (es) | Formulaciones acuosas de acetaminofen para inyeccion. | |
| CN102440957A (zh) | 醋酸特利加压素鼻腔喷雾剂及其制备方法 | |
| CN101972257B (zh) | 一种含有莫西沙星的药物组合物 | |
| AR062894A1 (es) | Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (ths) |